These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2304580)
21. [Anaphylaxis following administration of polidocanol]. Jagtman BA; Balmus KJ Ned Tijdschr Geneeskd; 1990 Apr; 134(17):872. PubMed ID: 1692610 [No Abstract] [Full Text] [Related]
22. Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study. Kahle B; Leng K Dermatol Surg; 2004 May; 30(5):723-8; discussion 728. PubMed ID: 15099314 [TBL] [Abstract][Full Text] [Related]
23. Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report. Brzoza Z; Kasperska-Zajac A; Rogala E; Rogala B Angiology; 2007; 58(5):644-6. PubMed ID: 18024951 [TBL] [Abstract][Full Text] [Related]
24. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence. Todd KL; Wright DI; Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535 [TBL] [Abstract][Full Text] [Related]
25. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971 [TBL] [Abstract][Full Text] [Related]
26. Reversible neurological deficit after foam sclerotherapy. Hartmann K; Harms L; Simon M Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):648-9. PubMed ID: 19683463 [TBL] [Abstract][Full Text] [Related]
27. Embolia cutis medicamentosa of the foot after sclerotherapy. Geukens J; Rabe E; Bieber T Eur J Dermatol; 1999 Mar; 9(2):132-3. PubMed ID: 10066964 [TBL] [Abstract][Full Text] [Related]
28. [A case of rectal varices treated with endoscopic injection sclerotherapy]. Zeniya A; Odashima M; Takahashi H; Ohkubo S; Masamune O Nihon Shokakibyo Gakkai Zasshi; 1997 Jan; 94(1):38-43. PubMed ID: 9028142 [No Abstract] [Full Text] [Related]
29. The role of sclerotherapy in abnormal varicose hand veins. Duffy DM; Garcia C; Clark RE Plast Reconstr Surg; 1999 Oct; 104(5):1474-9; discussion 1480-1. PubMed ID: 10513934 [TBL] [Abstract][Full Text] [Related]
30. Sclerotherapy--translucidation of the skin prior to injection. Scarborough DA; Bisaccia E J Dermatol Surg Oncol; 1989 May; 15(5):498-9. PubMed ID: 2715482 [TBL] [Abstract][Full Text] [Related]
31. Re: Polidocanol concentration and time affect the properties of foam used for sclerotherapy. Cameron E Dermatol Surg; 2012 Feb; 38(2):290. PubMed ID: 22309639 [No Abstract] [Full Text] [Related]
33. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial. Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB Trials; 2014 Dec; 15():497. PubMed ID: 25527165 [TBL] [Abstract][Full Text] [Related]